Board Member

Les Kaplan, PhD, has served on Nicox’ board of directors since October 2014. He was the executive chairman of Aciex Therapeutics, Inc., a pharmaceutical development company in ophthalmology acquired by Nicox in October 2014. He is an independent board member of Beacon Therapeutics.

Dr. Kaplan began his career at Allergan Inc., where he served as the Executive Vice President and President, Research & Development and Global Botox, and a board member of Allergan. During his tenure heading Allergan's R&D function more than 20 major pharmaceutical products and new indications were approved by the FDA, the European Union, Japan and major Ministries of Health around the world. Prior to joining Allergan, Dr. Kaplan held research positions at the Upjohn Company and at the University of California, Los Angeles. He previously served as a member of the board of directors of Acadia Pharmaceuticals, Acucela Inc., Altheos (Executive Chair), Neurotech, Oculex and National Neurovision Research Institute (FFB). Dr. Kaplan received a Ph.D. in organic chemistry from the University of California, Los Angeles.